Search Medical Condition
Please enter condition
Please choose location from dropdown

Allergy (Pediatric) Clinical Trials

A listing of Allergy (Pediatric) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (20) clinical trials

The purpose of this study is to evaluate the safety and tolerability of topical INCB018424 cream applied to pediatric subjects (≥ 12 to 17 years) with atopic dermatitis (AD).

Phase

Ragweed pollen is one of the most common inhaled allergens in North America and affects 40% of children. This study will evaluate an investigational pill. The only other immunotherapy has been allergy injections at a doctor’s office. The advantage of the pill is it can be administered under medical supervision ...

Phase

Does your child have Ragweeed Allergy or Hayfever? If so, your child may be eligible to participate in a research study of an investigational medication used to treat Allergies in children ages 4-17.

Phase

Allergy study for adolescents ages 12 to 17 who are allergic to ragweed. Ragweed is a fall pollen. If you have allergy symptoms such as sneezing, runny or itchy nose, stuffy or congested nose, or itchy and watery eyes starting mid-August that last to the first frost, you could be ...

Phase

Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days.

Phase N/A

The purpose of this clinical research study to test how well and how safe an investigational medication works in children and adolescent with HAE. Winthrop University Hospital Clinical Trials Center is conducting this clinical research study for children and adolescents, ages 2- 15 years old who have been diagnosed with ...

Phase N/A

A randomized, double-blind, placebo-controlled, multi-center study to assess the safety, tolerability and immunologic effects of HAL-MPE1 subcutaneous immunotherapy in adult and pediatric subjects with peanut allergy.

Phase

The primary objective for part A of the study is to characterize the safety and pharmacokinetics (PK) of dupilumab administered as a single dose in pediatric patients, 6 months to less than 6 years of age with severe atopic dermatitis (AD). The primary objective for part B of the study ...

Phase

Complete 4 visits over 4 weeks No Blood draws

Phase N/A

The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children

In Canada, the most common chronic disease of childhood is asthma. Childhood asthma places a significant burden on the health care system (refn). No objective preschool asthma diagnostic tools exist, and the current gold-standard, the Asthma Predictive Index, does not provide information about lung function and symptom management. In this ...

Phase N/A